Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Scope of the Report:
This report focuses on the Intravenous Solutions in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Baxter
Hospira
B. Braun Melsungen
Fresenius Kabi
Claris Lifesciences
Grifols
Vifor Pharma
JW Life Science
Market Segment by Countries, covering
Germany
UK
France
Russia
Italy
Market Segment by Type, covers
Crystalloids
Colloids
Others
Market Segment by Applications, can be divided into
Basic IV Solutions
Nutrient Infusion Solution
Others
There are 17 Chapters to deeply display the Europe Intravenous Solutions market.
Chapter 1, to describe Intravenous Solutions Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Intravenous Solutions, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Intravenous Solutions, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017;
Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications;
Chapter 12, Intravenous Solutions market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 15, to describe Intravenous Solutions sales channel, distributors, traders, dealers etc.
Chapter 16 and 17, to describe Intravenous Solutions Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents
1 Market Overview
1.1 Intravenous Solutions Introduction
1.2 Market Analysis by Type
1.2.1 Crystalloids
1.2.2 Colloids
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Basic IV Solutions
1.3.2 Nutrient Infusion Solution
1.3.3 Others
1.4 Market Analysis by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Profile
2.1.2 Intravenous Solutions Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Baxter Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Baxter News
2.2 Hospira
2.2.1 Profile
2.2.2 Intravenous Solutions Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Hospira Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Hospira News
2.3 B. Braun Melsungen
2.3.1 Profile
2.3.2 Intravenous Solutions Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 B. Braun Melsungen Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 B. Braun Melsungen News
2.4 Fresenius Kabi
2.4.1 Profile
2.4.2 Intravenous Solutions Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Fresenius Kabi Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Fresenius Kabi News
2.5 Claris Lifesciences
2.5.1 Profile
2.5.2 Intravenous Solutions Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Claris Lifesciences Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Claris Lifesciences News
2.6 Grifols
2.6.1 Profile
2.6.2 Intravenous Solutions Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Grifols Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Grifols News
2.7 Vifor Pharma
2.7.1 Profile
2.7.2 Intravenous Solutions Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Vifor Pharma Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Vifor Pharma News
2.8 JW Life Science
2.8.1 Profile
2.8.2 Intravenous Solutions Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 JW Life Science Intravenous Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 JW Life Science News
3 Europe Intravenous Solutions Market Competition, by Manufacturer
3.1 Europe Intravenous Solutions Sales and Market Share by Manufacturer (2016-2017)
3.2 Europe Intravenous Solutions Revenue and Market Share by Manufacturer (2016-2017)
3.3 Europe Intravenous Solutions Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Solutions Manufacturer Market Share
3.4.2 Top 5 Intravenous Solutions Manufacturer Market Share
3.5 Market Competition Trend
4 Europe Intravenous Solutions Market Analysis by Countries (2012-2017)
4.1 Europe Intravenous Solutions Sales Market Share by Countries (2012-2017)
4.2 Europe Intravenous Solutions Sales by Countries (2012-2017)
4.3 Europe Intravenous Solutions Revenue (Value) by Countries (2012-2017)
5 Europe Market Segmentation Intravenous Solutions by Type
5.1 Europe Intravenous Solutions Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 Europe Intravenous Solutions Sales and Market Share by Type (2012-2017)
5.1.2 Europe Intravenous Solutions Revenue and Market Share by Type (2012-2017)
5.2 Crystalloids Sales Growth and Price
5.2.1 Europe Crystalloids Sales Growth (2012-2017)
5.2.2 Europe Crystalloids Price (2012-2017)
5.3 Colloids Sales Growth and Price
5.3.1 Europe Colloids Sales Growth (2012-2017)
5.3.2 Europe Colloids Price (2012-2017)
5.4 Others Sales Growth and Price
5.4.1 Europe Others Sales Growth (2012-2017)
5.4.2 Europe Others Price (2012-2017)
6 Europe Market Segmentation Intravenous Solutions by Application
6.1 Europe Intravenous Solutions Sales Market Share by Application (2012-2017)
6.2 Basic IV Solutions Sales Growth (2012-2017)
6.3 Nutrient Infusion Solution Sales Growth (2012-2017)
6.4 Others Sales Growth (2012-2017)
7 Germany Intravenous Solutions Sales, Revenue, by Type, Application and Manufacturers
7.1 Germany Intravenous Solutions Revenue, Sales and Growth Rate (2012-2017)
7.2 Germany Intravenous Solutions Sales and Market Share by Type (2012-2017)
7.3 Germany Intravenous Solutions Sales by Application (2012-2017)
7.4 Germany Intravenous Solutions Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 Germany Intravenous Solutions Sales and Market Share by Manufacturer (2016-2017)
7.4.2 Germany Intravenous Solutions Revenue and Market Share by Manufacturer
7.5 Germany Intravenous Solutions Export and Import (2012-2017)
8 UK Intravenous Solutions Sales, Revenue, by Type, Application and Manufacturers
8.1 UK Intravenous Solutions Revenue, Sales and Growth Rate (2012-2017)
8.2 UK Intravenous Solutions Sales and Market Share by Type (2012-2017)
8.3 UK Intravenous Solutions Sales by Application (2012-2017)
8.4 UK Intravenous Solutions Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 UK Intravenous Solutions Sales and Market Share by Manufacturer
8.4.2 UK Intravenous Solutions Revenue and Market Share by Manufacturer
8.5 UK Intravenous Solutions Export and Import (2012-2017)
9 France Intravenous Solutions Sales, Revenue, by Type, Application and Manufacturers
9.1 France Intravenous Solutions Revenue, Sales and Growth Rate (2012-2017)
9.2 France Intravenous Solutions Sales and Market Share by Type (2012-2017)
9.3 France Intravenous Solutions Sales by Application (2012-2017)
9.4 France Intravenous Solutions Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 France Intravenous Solutions Sales and Market Share by Manufacturer
9.4.2 France Intravenous Solutions Revenue and Market Share by Manufacturer
9.5 France Intravenous Solutions Export and Import (2012-2017)
10 Russia Intravenous Solutions Sales, Revenue, by Type, Application and Manufacturers
10.1 Russia Intravenous Solutions Revenue, Sales and Growth Rate (2012-2017)
10.2 Russia Intravenous Solutions Sales and Market Share by Type
10.3 Russia Intravenous Solutions Sales by Application (2012-2017)
10.4 Russia Intravenous Solutions Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Russia Intravenous Solutions Sales and Market Share by Manufacturer
10.4.2 Russia Intravenous Solutions Revenue and Market Share by Manufacturer
10.5 Russia Intravenous Solutions Export and Import (2012-2017)
11 Italy Intravenous Solutions Sales, Revenue, by Type, Application and Manufacturers
11.1 Italy Intravenous Solutions Revenue, Sales and Growth Rate (2012-2017)
11.2 Italy Intravenous Solutions Sales and Market Share by Type
11.3 Italy Intravenous Solutions Sales by Application (2012-2017)
11.4 Italy Intravenous Solutions Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 Italy Intravenous Solutions Sales and Market Share by Manufacturer
11.4.2 Italy Intravenous Solutions Revenue and Market Share by Manufacturer
11.5 Italy Intravenous Solutions Export and Import (2012-2017)
12 Intravenous Solutions Market Forecast (2017-2022)
12.1 Europe Intravenous Solutions Sales, Revenue and Growth Rate (2017-2022)
12.2 Intravenous Solutions Market Forecast by Countries (2017-2022)
12.2.1 Germany Intravenous Solutions Sales Forecast (2017-2022)
12.2.2 UK Intravenous Solutions Sales Forecast (2017-2022)
12.2.3 France Intravenous Solutions Sales Forecast (2017-2022)
12.2.4 Russia Intravenous Solutions Sales Forecast (2017-2022)
12.2.5 Italy Intravenous Solutions Sales Forecast (2017-2022)
12.3 Intravenous Solutions Market Forecast by Type (2017-2022)
12.4 Intravenous Solutions Market Forecast by Application (2017-2022)
13 Intravenous Solutions Manufacturing Cost Analysis
13.1 Intravenous Solutions Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Intravenous Solutions
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Intravenous Solutions Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Intravenous Solutions Major Manufacturers in 2015
14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source